Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$71,000 |
 |
Johnson & JohnsonJNJ |
-$230,000 |
 |
ModernaMRNA |
$16,000 |
 |
AbbVieABBV |
$88,000 |
 |
Eli Lilly and CompanyLLY |
-$250,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros | Dec 18, 2025 | Buy | $1K - $15K |
| Julia Letlow | Dec 8, 2025 | Buy | $1K - $15K |
| Gilbert Cisneros | Nov 19, 2025 | Buy | $1K - $15K |
| Lisa McClain | Oct 31, 2025 | Sell | $1K - $15K |
| Lisa McClain | Oct 30, 2025 | Sell | $1K - $15K |
| Gilbert Cisneros | Oct 21, 2025 | Buy | $1K - $15K |
| Val Hoyle | Sep 23, 2025 | Sell | $1K - $15K |
| Lisa McClain | Jul 22, 2025 | Buy | $1K - $15K |
| Lisa McClain | Jun 9, 2025 | Buy | $1K - $15K |
| Bruce Westerman | Apr 21, 2025 | Sell | $1K - $15K |
| Bruce Westerman | Mar 3, 2025 | Buy | $1K - $15K |
| Valerie Hoyle | Oct 29, 2024 | Buy | $1K - $15K |
FAQ - Congress Trading
Gilbert Cisneros purchased Astrazeneca shares most recently on December 18, 2025.
Gilbert Cisneros has bought the most AZN stock in the last 2 years, with an estimated value of $24,000.
Lisa McClain has sold the most AZN stock in the last 2 years, with an estimated value of $16,000.
According to our estimates, the net value of trades by US politicians for Astrazeneca in the last 2 years is positive, amounting to $32,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
Over the last 2 years, insider transactions for Astrazeneca have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
